city New Delhi India city Ahmedabad covid-19 testing infection patient city New Delhi India city Ahmedabad

CSIR to test its new sepsis drug for severe patients of Covid-19

Reading now: 232
www.livemint.com

NEW DELHI : Raising hopes for a potential treatment of Covid-19, India’s premier research organization Council of Scientific and Industrial Research (CSIR) has decided to test its new drug against Sepsis to treat critical patients of Covid-19.

The drug has recently been approved for marketing in India and would be available commercially as Sepsivac® from Ahmedabad-based Cadila Pharmaceuticals Limited.

The pharmaceutical company was supported by CSIR laboratories led by Indian Institute of Integrative Medicine (IIIM), Jammu in development of this drug, which has also found effective for leprosy patients. “This is a moment of pride for all of us as, as it is the only such drug in the global market which has been approved to treat

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA